Scientists identify Alzheimer's disease-protective genetic factors and unravel disease mechanisms

Scientists identify Alzheimer's disease-protective genetic factors and unravel disease mechanisms

An international research team has identified key genetic factors that confer protective effects against Alzheimer's disease (AD) through a comprehensive genetic analysis of East Asian populations, including Chinese and Japanese, as well as European populations. This groundbreaking discovery sheds light on how these genetic factors can exert protective effects, unveiling the biological mechanisms underlying AD pathogenesis.

Comprehensive genetic analysis identifies protective factors against Alzheimer's disease

An international research team led by the Hong Kong University of Science and Technology (HKUST) has identified key genetic factors that confer protective effects against Alzheimer's disease (AD) through a comprehensive genetic analysis of East Asian populations, including Chinese and Japanese, as well as European populations.

#Coya Therapeutics Demonstrates Promising Results in Alzheimer?s Disease with IL-2 Therapy Based on Inflammatory Blo...

Houston-based Coya Therapeutics, Inc., a clinical-stage biotechnology company focusing on the enhancement of regulatory T cell (Treg) function, has announced promising results from a recent study evaluating low-dose interleukin-2 (LD IL-2) as a potential therapeutic approach for Alzheimer's disease (AD). The company's announcement follows the completion of an investigator-initiated, 21-week, double-blind, placebo-controlled Phase 2 study that ex…

Alzheimer's Disease Blood Biomarker Test Improves Clinical Decision-Making

Summary:The use of the PrecivityAD2 blood biomarker test significantly improved clinicians’ confidence in diagnosing Alzheimer’s disease, enhancing patient management and care outcomes. Takeaways: Enhanced Diagnostic Confidence: Clinicians’ certainty in diagnosing Alzheimer’s disease rose to over 90% with positive test results. Impact on Medication and Testing: Positive results led to a 35% increase in AD medication prescriptions, while negativ…